Innoxel Lifesciences Private Limited

Manufactures and sells a variety of pharmaceutical and natural products using advanced technologies.

2020 | Vadodara, Gujarat (India) | Active
Last Updated: November 15, 2024

Innoxel Lifesciences Profile

Key Indicators

  • Authorised Capital ₹ 100.00 Cr
  • Paid Up Capital ₹ 90.01 Cr
  • Company Age 4 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 85.20 Cr
  • Revenue Growth 8545.45%
  • Profit Growth -168.12%
  • Ebitda -174.07%
  • Net Worth 672.34%
  • Total Assets 234.94%

About Innoxel Lifesciences

Innoxel Lifesciences Private Limited (ILPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 October 2020 (Four years and four months 5 days old ). Its registered office is in Vadodara, Gujarat, India.

The Company is engaged in the Chemicals And Materials Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 90.01 Cr.

The company currently has active open charges totaling ₹85.20 Cr.

The Key Managerial Personnel (KMP) at Innoxel Lifesciences Private Limited India is Krutika Bhattbhatt as COMPANY SECRETARY. Mukeshbhai Patel, Bharatkumar Desai, Himaben Desai, and Three other members serve as directors at the Company.

Company Details

  • Location

    Vadodara, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    innoxells.com

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24290GJ2020PTC117407

  • Company No.

    117407

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    16 Oct 2020

  • Date of AGM

    02 Jul 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Chemicals and Materials

Who are the key members and board of directors at Innoxel Lifesciences?

Executive Team (1)

NameDesignationAppointment DateStatus
Krutika Bhattbhatt Country flag representing In Company Secretary04-Jan-2024Current

Board Members (6)

NameDesignationAppointment DateStatus
Mukeshbhai Patel Country flag representing In Director Current
Bharatkumar Desai Country flag representing In Whole-Time Director 16-Oct-2020Current
Himaben Desai Country flag representing In Director 16-Oct-2020Current
Bhahim Desai Country flag representing In Director 16-Oct-2020Current
Zankhana Sheth Country flag representing In Director Current
Puspaben Trivedi Country flag representing In Director 16-Oct-2020Current

Financial Performance of Innoxel Lifesciences.

Innoxel Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 8545.45% increase. The company also saw a substantial fall in profitability, with a 168.12% decrease in profit. The company's net worth Soared by an impressive increase of 672.34%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
8545.45%
Revenue from Operations
Total Assets
234.94%
Profit or Loss
-168.12%
Net Worth
672.34%
EBITDA
-174.07%

What is the Ownership and Shareholding Structure of Innoxel Lifesciences?

In 2023, Innoxel Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹85.20 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 85.00 Cr
  • Hdfc Bank Limited : 0.20 Cr

Latest Charge Details

DateLenderAmountStatus
20 Dec 2023Hdfc Bank Limited₹2.00 MOpen
31 Mar 2023Axis Bank Limited₹85.00 CrOpen

How Many Employees Work at Innoxel Lifesciences?

Innoxel Lifesciences has a workforce of 117 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Innoxel Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innoxel Lifesciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Innoxel Lifesciences

Recent activity within the organization

  • Annual General Meeting

    Innoxel Lifesciences Private Limited last Annual general meeting of members was held on 02 Jul 2024 as per latest MCA records.

    02 Jul 2024

  • Balance Sheet

    Innoxel Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

    31 Mar 2024

  • Director Appointment

    Krutika Padmakar Bhattbhatt was appointed as a Company Secretary was appointed as a Company Secretary on 04 Jan 2024 & has been associated with this company since 1 year 1 month .

    04 Jan 2024

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.20 Cr with Charge ID 100840371 was registered on 20 Dec 2023.

    20 Dec 2023

  • Charges

    A charge with Axis Bank Limited of Rs. 85.00 Cr registered on 31 Mar 2023 with Charge ID 100708829 was modified on 18 Oct 2023.

    18 Oct 2023

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 85.00 Cr with Charge ID 100708829 was registered on 31 Mar 2023.

    31 Mar 2023

Frequently asked questions

  • Innoxel Lifesciences Private Limited was incorporated on 16 Oct 2020.

  • The authorized share capital of Innoxel Lifesciences Private Limited is ₹ 100.00 Cr and paid-up capital is ₹ 90.01 Cr.

  • Currently 7 directors are associated with Innoxel Lifesciences Private Limited.

    • Mukeshbhai Jivrajbhai Patel
    • Bharatkumar Rameshchandra Desai
    • Himaben Bharatkumar Desai
    • Bhahim Bharatkumar Desai
    • Zankhana Bimalkumar Sheth
    • Puspaben Fulashankerbhai Trivedi
    • Krutika Padmakar Bhattbhatt
  • As per Ministry of Corporate Affairs (Mca), the registered address of Innoxel Lifesciences Private Limited is Survey No.144 /146 Po.Hari Pura Tal Savli, Dist- India, Baroda, Gujarat, 391520.

  • The corporate identification number (CIN) of Innoxel Lifesciences Private Limited is U24290GJ2020PTC117407 and the company number is 117407 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Innoxel Lifesciences Private Limited is https://www.innoxells.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Innoxel Lifesciences Private Limited has risen by 8545.45%.

  • As Per 2023 financial reports, 117 employees are currently employed by Innoxel Lifesciences Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Innoxel Lifesciences Private Limited has experienced an upsurge of 672.34%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Innoxel Lifesciences Private Limited amount to ₹ 85.20 Cr.

  • The most recent Balance Sheet for Innoxel Lifesciences Private Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Industrial Chemicals